- Home
- NVO vs IBM Comparison
NVO vs IBM Comparison
Compare NVO & IBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVO
- IBM
- Stock Information
- Founded
- NVO 1923
- IBM 1911
- Country
- NVO Denmark
- IBM United States
- Employees
- NVO N/A
- IBM N/A
- Industry
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- IBM Computer Manufacturing
- Sector
- NVO Health Care
- IBM Technology
- Exchange
- NVO Nasdaq
- IBM Nasdaq
- Market Cap
- NVO 278.0B
- IBM 249.5B
- IPO Year
- NVO N/A
- IBM N/A
- Fundamental
- Price
- NVO $71.49
- IBM $258.80
- Analyst Decision
- NVO Strong Buy
- IBM Buy
- Analyst Count
- NVO 4
- IBM 14
- Target Price
- NVO $128.00
- IBM $254.86
- AVG Volume (30 Days)
- NVO 11.1M
- IBM 3.7M
- Earning Date
- NVO 05-07-2025
- IBM 07-23-2025
- Dividend Yield
- NVO 2.25%
- IBM 2.59%
- EPS Growth
- NVO 17.93
- IBM N/A
- EPS
- NVO 3.40
- IBM 5.83
- Revenue
- NVO $43,922,211,349.00
- IBM $62,832,000,000.00
- Revenue This Year
- NVO $18.59
- IBM $6.42
- Revenue Next Year
- NVO $15.61
- IBM $4.34
- P/E Ratio
- NVO $20.13
- IBM $44.30
- Revenue Growth
- NVO 24.11
- IBM 1.23
- 52 Week Low
- NVO $57.00
- IBM $163.53
- 52 Week High
- NVO $148.15
- IBM $269.28
- Technical
- Relative Strength Index (RSI)
- NVO 59.49
- IBM 54.86
- Support Level
- NVO $68.30
- IBM $256.77
- Resistance Level
- NVO $71.30
- IBM $265.00
- Average True Range (ATR)
- NVO 1.96
- IBM 4.95
- MACD
- NVO 0.60
- IBM -0.67
- Stochastic Oscillator
- NVO 99.17
- IBM 57.45
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About IBM International Business Machines Corporation
IBM looks to be a part of every aspect of an enterprise's IT needs. The company primarily sells software, IT services, consulting, and hardware. IBM operates in 175 countries and employs approximately 300,000 people. The company has a robust roster of business partners to service its clients, which include 95% of all Fortune 500 companies. Primary products include its mainframes, Red Hat software, transaction processing software, and IT consulting.